INCYTE CORPORATION revenue breakdown overview

INCYTE CORPORATION revenue for the last year amounted to 3.11 B CHF, the most of which — 3.11 B CHF — came from its highest performing source at the moment, Proprietary Therapeutics, the year earlier bringing 3.14 B CHF. The greatest contribution to the revenue figure was made by United States — last year it brought INCYTE CORPORATION 2.95 B CHF, and the year before that — 2.96 B CHF.